https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/biocon-biologics-concludes-integration-of-acquired-biosimilars-business-in-120-countries/ 2025-08-06T18:05:45+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/biocon-ranked-no-8-among-science-magazines-best-employers-in-global-biotech-and-pharma-sector/ 2025-08-06T18:07:04+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/bbl-continues-to-expand-global-footprint-completes-biosimilars-business-in-usa/ 2025-08-07T04:41:40+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/after-five-years-of-successful-experience-hulio-available-in-the-united-states/ 2025-08-07T04:43:13+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/biocon-biologics-announces-new-dermatology-data-to-be-presented-at-eadv-congress-2024/ 2025-08-07T04:51:51+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/biocon-continues-to-be-among-science-magazines-top-10-global-employers-list/ 2025-08-07T04:53:56+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/biocon-biologics-to-present-at-the-43rd-annual-j-p-morgan-healthcare-conference/ 2025-08-07T04:56:41+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/company-statements/u-s-fda-classifies-biocon-biologics-site-in-johor-bahru-malaysia-as-voluntary-action-indicated-vai/ 2025-08-18T05:46:18+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/company-statements/biocon-biologics-receives-complete-response-letter-from-u-s-fda-for-biosimilar-insulin-aspart/ 2025-08-18T07:27:09+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/company-statements/u-s-fda-completes-two-cgmp-inspections-at-biocon-biologics-insulins-facility-in-malaysia/ 2025-08-18T07:29:18+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/bbl-obtains-us-fda-approval-for-biosimilar-aflibercept-for-yesafili-enters-us-ophthalmology-market/ 2025-08-19T07:22:47+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/biocon-biologics-moves-into-new-north-american-headquarters-in-bridgewater-new-jersey/ 2025-08-19T07:25:41+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/biocon-biologics-announces-results-of-aflibercept-switching-study-at-american-academy-of-ophthalmology-annual-meeting/ 2025-08-19T07:27:00+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/company-statements/usfda-classifies-biocon-biologics-biocon-park-site-in-bengaluru-india/ 2025-08-19T07:38:48+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/company-statements/biocon-biologics-drug-substance-facility-in-bengaluru-classified-as-voluntary-action-indicated-vai/ 2025-08-19T07:40:37+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/company-statements/company-statement-on-bbevacizumab/ 2025-08-19T08:32:10+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/company-statements/us-fda-completes-inspection-at-biocon-biologics-insulins-facility-at-johor-bahru-malaysia/ 2025-08-19T08:34:05+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/company-statements/us-fda-completes-inspection-at-biocon-biologics-facilities-at-biocon-park-bengaluru-india/ 2025-08-19T08:35:58+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/company-statements/company-statement-on-aflibercept/ 2025-08-19T08:38:35+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/company-statements/update-on-u-s-fda-inspection-at-biocon-biologics-manufacturing-facility-in-johor-malaysia/ 2025-08-19T08:40:37+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/biocon-biologics-launches-yesintek-ustekinumab-kfce-biosimilar-to-stelara-in-the-united-states/ 2025-08-28T10:58:20+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/company-statements/u-s-fda-approves-biocon-biologics-yesintek-bmab-1200-biosimilar-to-jjs-stelara-ustekinumab/ 2025-09-19T12:45:08+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/bbl-civica-collaborate-to-expand-insulin-aspart-access-in-usa/ 2025-10-07T10:04:37+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/blogs/biocon-biologics-breaks-billion-dollar-barrier-with-58-rise-in-annual-revenue/ 2025-10-07T11:04:48+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/wp-content/uploads/2024/07/BBL-Billion-Dollar-Inner-Banner-v1.jpg https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/wp-content/uploads/2024/07/Shreehas-P-Tambe.jpg https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/blogs/biocon-biologics-opens-north-america-headquarters-in-new-jerseys-biopharma-corridor/ 2025-10-07T11:04:57+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/wp-content/uploads/2024/09/New-Jersey_Banner_v3_1920x550.jpg https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/wp-content/uploads/2025/04/Image1-1024x683.jpg https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/wp-content/uploads/2025/04/BioconBiologics_Proofs_1604-min-Copy.jpg https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/wp-content/uploads/2025/04/Image2.jpg https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/wp-content/uploads/2025/04/BioconBiologics_Proofs_1159-v1-1536x745-1-1024x497.jpg https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/wp-content/uploads/2025/04/Joshua-Salsi-1.jpg https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/biocon-biologics-receives-u-s-food-and-drug-administration-approval-for-bosaya-and-aukelso-denosumab-biosimilars/ 2025-10-07T12:03:32+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/blogs/biocon-biologics-makes-donation-to-insulin-for-life/ 2025-10-08T05:20:48+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/wp-content/uploads/2024/02/Insulin-BBL-Website-Banner-1.jpg https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/wp-content/uploads/2025/08/Insulin-image.jpg https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/wp-content/uploads/2025/08/Matthew-Edward-Erick.png https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/biocon-biologics-announces-us-fda-approval-for-jobevne/ 2025-10-08T20:15:34+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/biocon-biologics-secures-strong-market-access-coverage-for-yesintek-in-the-united-states/ 2025-10-08T20:15:34+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/biocon-biologics-expands-diabetes-portfolio-with-fda-approval-of-kirsty/ 2025-10-10T10:28:15+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/biocon-biologics-completes-one-year-as-an-integrated-global-biosimilars-enterprise/ 2025-10-13T06:47:05+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/biocon-biologics-secures-us-market-entry-date-for-bmab-1200-a-proposed-biosimilar-to-stelara/ 2025-10-13T06:58:26+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/media-coverage/uwe-gudat-m-d-new-biosimilar-data-bring-reassurance-for-patients-with-psoriasis/ 2025-10-13T08:34:48+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/media-coverage/a-conversation-with-joshua-salsi-head-of-north-america-biocon-biologics/ 2025-10-13T08:44:22+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/media-coverage/taking-control-of-our-destiny-biocon-biologics-ceo-tambe-celebrates-european-viatris-integration/ 2025-10-13T08:46:58+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/media-coverage/uwe-gudat-m-d-new-biosimilar-data-bring-reassurance-for-patients-with-psoriasis-2/ 2025-10-13T08:48:08+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/media-coverage/grxbiosims-panelists-discuss-regulatory-shifts-in-biosimilar-interchangeability/ 2025-10-13T08:49:31+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/media-coverage/panelists-stress-stakeholder-education-to-build-confidence-in-biosimilars/ 2025-10-13T08:50:05+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/media-coverage/new-campaign-targets-talent-by-showing-what-somerset-county-has-to-offer/ 2025-10-13T08:51:38+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/media-coverage/unifying-standards-the-need-for-streamlined-biosimilar-development/ 2025-10-13T08:51:39+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/media-coverage/quiet-giant-biocon-sets-out-vision-for-biosimilars-2/ 2025-10-13T08:52:56+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/media-coverage/the-future-of-biosimilars-qa-with-matt-erick/ 2025-10-13T08:53:45+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/media-coverage/biosimilar-uptake-appears-to-finally-be-on-the-upswing-and-biocon-biologics-is-betting-on-the-sectors-future/ 2025-10-13T08:59:44+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/media-coverage/fda-approves-biocon-biologics-yesafili/ 2025-10-13T09:00:19+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/media-coverage/generics-bulletin-explains-after-humira-biosimilars-will-it-be-groundhog-day-for-stelara/ 2025-10-13T09:00:47+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/biocon-biologics-and-civica-expand-partnership-and-launch-private-label-insulin/ 2025-11-05T12:17:14+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/biocon-biologics-to-expand-biosimilar-oncology-portfolio-outline-strategic-vision-at-the-2026-j-p-morgan-healthcare-conference/ 2026-01-30T09:21:57+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/media-coverage/automatic-biosimilar-substitution-and-patient-education-advocated-by-elena-wolff-holz-md/ 2026-02-05T07:07:05+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/media-coverage/biotech-entrepreneurs-kiran-mazumdar-shaw/ 2026-02-05T07:23:58+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/media-coverage/civica-rx-to-partner-with-biocon-biologics-and-california-state-to-expand-access-to-insulin-biosimilars-beginning-2026/ 2026-02-11T11:00:28+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/media-coverage/oncology-biosimilars-cut-costs-diabetes-and-other-diseases-could-follow-feat-shreehas-tambe/ 2026-02-11T11:01:29+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/uncategorized/biosimilar-execs-optimistic-about-future-for-u-s-biosims-feat-shreehas-tambe/ 2026-02-20T11:58:27+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/uncategorized/new-data-support-hulio-as-an-interchangeable-adalimumab-option/ 2026-02-20T11:59:30+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/biocon-biologics-secures-u-s-market-entry-date-for-bosaya-and-aukelso-denosumab-biosimilars/ 2026-04-09T02:02:17+00:00 https://uat-wp-bioconbiologicsus-us.bioconbiologicsit.com/news/press-releases/biocon-announces-u-s-commercial-launch-of-bosaya-and-aukelso-denosumab-biosimilars/ 2026-04-09T19:10:21+00:00